Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Bone Marrow Transplantation
|
April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma
S Fruehauf, J Klaus, J Huesing, et al.
Gene Therapy
|
April 21, 2001
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells
R Knipper, K Kuehlcke, B Schiedlmeier, et al.
Cells, Tissues, Organs
|
November 12, 2002
Gene therapy for sarcoma
S Fruehauf, M R Veldwijk, S Berlinghoff, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis
N Marschner, T Seufferlein, K Potthoff, et al.
Bone Marrow Transplantation
|
June 21, 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
F A Giordano, B Fehse, A Hotz-Wagenblatt, et al.
ESMO Open
|
July 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
A Ballhausen, M Karthaus, S Fruehauf, et al.
ESMO Open
|
July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)
K Heinrich, M Karthaus, S Fruehauf, et al.
BMC Cancer
|
July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
G Sommerhäuser, A Kurreck, S Stintzing, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
[Not Available]
Thomas G Wendt, G Gademann, C Pambor, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Bone Marrow Transplantation
|
April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma
S Fruehauf, J Klaus, J Huesing, et al.
Gene Therapy
|
April 21, 2001
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells
R Knipper, K Kuehlcke, B Schiedlmeier, et al.
Cells, Tissues, Organs
|
November 12, 2002
Gene therapy for sarcoma
S Fruehauf, M R Veldwijk, S Berlinghoff, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis
N Marschner, T Seufferlein, K Potthoff, et al.
Bone Marrow Transplantation
|
June 21, 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
F A Giordano, B Fehse, A Hotz-Wagenblatt, et al.
ESMO Open
|
July 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
A Ballhausen, M Karthaus, S Fruehauf, et al.
ESMO Open
|
July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)
K Heinrich, M Karthaus, S Fruehauf, et al.
BMC Cancer
|
July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
G Sommerhäuser, A Kurreck, S Stintzing, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
[Not Available]
Thomas G Wendt, G Gademann, C Pambor, et al.
Page
of 6